• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝集素组织化学显示胆管癌中存在异常糖基化。

Aberrant glycosylation in cholangiocarcinoma demonstrated by lectin-histochemistry.

作者信息

Indramanee Somsiri, Silsirivanit Atit, Pairojkul Chawalit, Wongkham Chaisiri, Wongkham Sopit

机构信息

Department of Biochemistry, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Asian Pac J Cancer Prev. 2012;13 Suppl:119-24.

PMID:23480752
Abstract

Cholangiocarcinoma (CCA) is an aggressive malignant tumor which is difficult to diagnose at an early stage. Because no reliable CCA specific markers are available at present, most patients are diagnosed after late clinical presentation. In many tumors, aberrant glycans participate in various steps of pathogenesis and progression. In this study, we investigated aberrant glycosylation in CCA tissues using lectin histochemistry to allow associations of specific glycans with clinicopathological features of the patients to be investigated. For this purpose, 14 lectins specific to 5 main glycan structures were used for screening. Nine lectins showed positive staining in hepatocyte sand stromal cells in liver tissues whereas three lectins, sWGA, SJA and UEA-I, had negative lectin binding to hepatocytes and normal bile duct epithelia but exhibited positive staining with CCA. sWGA was selected for further evaluation of (β-D-GlcNAc)n-glycoconjugate expressions in 44 CCA tissues. We found that sWGA- specific glycans were aberrantly expressed along with CCA development and the level of expression varied with histological types. It was highly expressed in papillary and well-differentiated types but was significantly reduced in poorly-differentiated lesions. Specific associations of sWGA-specific glycoconjugate expression with clinicopathological features or overall survival of patients were not apparent in this cohort study.

摘要

胆管癌(CCA)是一种侵袭性恶性肿瘤,早期难以诊断。由于目前尚无可靠的CCA特异性标志物,大多数患者在出现晚期临床表现后才被诊断出来。在许多肿瘤中,异常聚糖参与发病机制和进展的各个阶段。在本研究中,我们使用凝集素组织化学研究CCA组织中的异常糖基化,以研究特定聚糖与患者临床病理特征之间的关联。为此,使用了针对5种主要聚糖结构的14种凝集素进行筛选。9种凝集素在肝组织的肝细胞和基质细胞中呈阳性染色,而3种凝集素,即sWGA、SJA和UEA-I,与肝细胞和正常胆管上皮细胞的凝集素结合呈阴性,但在CCA中呈阳性染色。选择sWGA进一步评估44例CCA组织中(β-D-GlcNAc)n-糖缀合物的表达。我们发现,sWGA特异性聚糖随着CCA的发展而异常表达,表达水平因组织学类型而异。它在乳头状和高分化类型中高度表达,但在低分化病变中显著降低。在这项队列研究中,sWGA特异性糖缀合物表达与患者临床病理特征或总生存期之间没有明显的特定关联。

相似文献

1
Aberrant glycosylation in cholangiocarcinoma demonstrated by lectin-histochemistry.凝集素组织化学显示胆管癌中存在异常糖基化。
Asian Pac J Cancer Prev. 2012;13 Suppl:119-24.
2
Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.GalNAc 糖基化聚糖在胆管癌中的临床意义:诊断和预后价值。
Clin Chim Acta. 2018 Feb;477:66-71. doi: 10.1016/j.cca.2017.12.005. Epub 2017 Dec 5.
3
A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Agglutinin.凝集素检测到的新型胆管癌血清糖生物标志物用于诊断和预后
Molecules. 2021 May 8;26(9):2782. doi: 10.3390/molecules26092782.
4
Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.肝内胆管结石所致胆管癌的凝集素组织化学研究
J Surg Oncol. 1995 Jun;59(2):131-5. doi: 10.1002/jso.2930590211.
5
Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines.胆管癌细胞系中O-糖蛋白聚糖的差异表达
Asian Pac J Cancer Prev. 2016;17(2):691-5. doi: 10.7314/apjcp.2016.17.2.691.
6
Aberrant expression of CD44 in bile duct cancer correlates with poor prognosis.CD44在胆管癌中的异常表达与预后不良相关。
Asian Pac J Cancer Prev. 2012;13 Suppl:95-9.
7
Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.MAL-II 结合的 α2,3-唾液酸化聚糖增加与胆管癌患者对 5-FU 的耐药性和短生存期相关。
Medicina (Kaunas). 2019 Nov 28;55(12):761. doi: 10.3390/medicina55120761.
8
Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.多种血清糖生物标志物可改善胆管癌的诊断和预后预测。
Clin Chim Acta. 2020 Nov;510:142-149. doi: 10.1016/j.cca.2020.07.017. Epub 2020 Jul 11.
9
STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.信号转导和转录激活因子(STATs)分析显示,在胆管癌的发生和发展过程中,主要是STAT3被激活。
J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):767-76. doi: 10.1002/jhbp.131. Epub 2014 Jul 16.
10
The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.SOCS3和A20在人类胆管癌中的预后作用
PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.

引用本文的文献

1
Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma.波罗蜜凝集素结合聚糖对胆管癌预后和治疗的临床影响
Sci Rep. 2025 Jan 2;15(1):436. doi: 10.1038/s41598-024-84444-7.
2
Lectin-glycan interactions: a comprehensive cataloguing of cancer-associated glycans for biorecognition and bio-alteration: a review.凝集素-糖相互作用:用于生物识别和生物修饰的癌症相关糖的综合目录:综述。
Glycoconj J. 2024 Oct;41(4-5):301-322. doi: 10.1007/s10719-024-10161-y. Epub 2024 Sep 2.
3
Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
Wisteria floribunda agglutinin 结合糖在胆管癌发生和转移中的作用。
Histochem Cell Biol. 2024 May;161(5):423-434. doi: 10.1007/s00418-024-02270-4. Epub 2024 Feb 23.
4
Combined analysis of secreted proteins and glycosylation identifies prognostic features in cholangiocarcinoma.联合分析分泌蛋白和糖基化鉴定出胆管癌的预后特征。
J Cell Physiol. 2024 Mar;239(3):e31147. doi: 10.1002/jcp.31147. Epub 2023 Nov 3.
5
Lectins as Biomarkers of IC/BPS Disease: A Comparative Study of Glycosylation Patterns in Human Pathologic Urothelium and IC/BPS Experimental Models.凝集素作为间质性膀胱炎/膀胱疼痛综合征疾病的生物标志物:人类病理性尿路上皮和间质性膀胱炎/膀胱疼痛综合征实验模型中糖基化模式的比较研究
Diagnostics (Basel). 2022 Apr 25;12(5):1078. doi: 10.3390/diagnostics12051078.
6
Precision N-glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma.精准 N-糖蛋白质组学揭示 LacdiNAc 升高是肝内胆管癌的一个新特征。
Mol Oncol. 2022 Jun;16(11):2135-2152. doi: 10.1002/1878-0261.13147. Epub 2021 Dec 18.
7
A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Agglutinin.凝集素检测到的新型胆管癌血清糖生物标志物用于诊断和预后
Molecules. 2021 May 8;26(9):2782. doi: 10.3390/molecules26092782.
8
High expression of tissue -linked glycans is associated with a malignant phenotype of cholangiocarcinoma.组织相关糖链的高表达与胆管癌的恶性表型相关。
J Int Med Res. 2021 Feb;49(2):300060520976864. doi: 10.1177/0300060520976864.
9
Ganglioside GM2: a potential biomarker for cholangiocarcinoma.神经节苷脂GM2:胆管癌的一种潜在生物标志物。
J Int Med Res. 2020 Jul;48(7):300060520903216. doi: 10.1177/0300060520903216.
10
Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.MAL-II 结合的 α2,3-唾液酸化聚糖增加与胆管癌患者对 5-FU 的耐药性和短生存期相关。
Medicina (Kaunas). 2019 Nov 28;55(12):761. doi: 10.3390/medicina55120761.